-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA Clears Cereno Scientific to Begin Phase IIb Trial of CS1 in Pulmonary Arterial Hypertension

Reuters·12/08/2025 21:26:16

Please log in to view news